麻豆传媒

Melissa Alsina, MD, discusses the data on this anti-BCMA CAR T-cell therapy

Secondary analysis examined quality of life, fatigue, and depression

New database might help explain progression and resistance, says Rafael Renatino-Canevarolo, PhD

Bispecific antibody passes first-in-human study

Joseph Mikhael, MD, discusses the CAR-T cell therapy trials from ASH 2020

Next generation sequencing is playing an increasing role

Deepu Madduri, MD, discusses the CARTITUDE-1 trial

Study clarifies if clearance prior to transplantation could influence outcomes

Owen O'Connor, MD, thinks we are ready to turn the corner with some novel combinations

Joseph Jurcic, MD, on study showing more patients able to undergo transplant, surviving longer with less relapse

Two abstracts were promising for patients with translocation 11;14